SE9602496D0 - Method and means for producing a fibrinogen binding protein and its use in biotechnology - Google Patents

Method and means for producing a fibrinogen binding protein and its use in biotechnology

Info

Publication number
SE9602496D0
SE9602496D0 SE9602496A SE9602496A SE9602496D0 SE 9602496 D0 SE9602496 D0 SE 9602496D0 SE 9602496 A SE9602496 A SE 9602496A SE 9602496 A SE9602496 A SE 9602496A SE 9602496 D0 SE9602496 D0 SE 9602496D0
Authority
SE
Sweden
Prior art keywords
protein
fibrinogen binding
producing
binding protein
biotechnology
Prior art date
Application number
SE9602496A
Other languages
English (en)
Swedish (sv)
Inventor
Bengt Guss
Martin Nilsson
Lars Frykberg
Jan-Ingmar Flock
Martin Kjell Lindberg
Original Assignee
Bengt Guss
Martin Nilsson
Lars Frykberg
Jan Ingmar Flock
Martin Kjell Lindberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bengt Guss, Martin Nilsson, Lars Frykberg, Jan Ingmar Flock, Martin Kjell Lindberg filed Critical Bengt Guss
Priority to SE9602496A priority Critical patent/SE9602496D0/xx
Publication of SE9602496D0 publication Critical patent/SE9602496D0/xx
Priority to AU32825/97A priority patent/AU3282597A/en
Priority to PCT/SE1997/001091 priority patent/WO1997048727A1/en
Priority to JP50281998A priority patent/JP4173549B2/ja
Priority to AT97928617T priority patent/ATE316979T1/de
Priority to ES97928617T priority patent/ES2258280T3/es
Priority to DE69735207T priority patent/DE69735207T2/de
Priority to EP97928617A priority patent/EP0922056B1/en
Priority to CA002294433A priority patent/CA2294433A1/en
Priority to US09/147,405 priority patent/US6733758B1/en
Priority to US10/806,288 priority patent/US7160990B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SE9602496A 1996-06-20 1996-06-20 Method and means for producing a fibrinogen binding protein and its use in biotechnology SE9602496D0 (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE9602496A SE9602496D0 (sv) 1996-06-20 1996-06-20 Method and means for producing a fibrinogen binding protein and its use in biotechnology
US09/147,405 US6733758B1 (en) 1996-06-20 1997-06-18 Fibrinogen binding protein originating from coagulase-negative staphylococcus
AT97928617T ATE316979T1 (de) 1996-06-20 1997-06-18 Neuartiges, fibrinogen-bindendes protein, welches von einem koagulase-negativen staphylokokkus abstammt
PCT/SE1997/001091 WO1997048727A1 (en) 1996-06-20 1997-06-18 New fibrinogen binding protein originating from coagulase-negative staphylococcus
JP50281998A JP4173549B2 (ja) 1996-06-20 1997-06-18 コアグラーゼ陰性ブドウ球菌に由来する、新規フィブリノーゲン結合たん白質
AU32825/97A AU3282597A (en) 1996-06-20 1997-06-18 New fibrinogen binding protein originating from coagulase-negative staphylococcus
ES97928617T ES2258280T3 (es) 1996-06-20 1997-06-18 Nueva proteina de union a fibrinogeno originada a partir de staphylococus coagulasa negativo.
DE69735207T DE69735207T2 (de) 1996-06-20 1997-06-18 Neuartiges, fibrinogen-bindendes protein, welches von einem koagulase-negativen staphylokokkus abstammt
EP97928617A EP0922056B1 (en) 1996-06-20 1997-06-18 New fibrinogen binding protein originating from coagulase-negative staphylococcus
CA002294433A CA2294433A1 (en) 1996-06-20 1997-06-18 New fibrinogen binding protein originating from coagulase-negative staphylococcus
US10/806,288 US7160990B2 (en) 1996-06-20 2004-03-23 Antibodies to a fibrinogen binding protein of staphylococcus epidermidis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9602496A SE9602496D0 (sv) 1996-06-20 1996-06-20 Method and means for producing a fibrinogen binding protein and its use in biotechnology

Publications (1)

Publication Number Publication Date
SE9602496D0 true SE9602496D0 (sv) 1996-06-20

Family

ID=20403140

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9602496A SE9602496D0 (sv) 1996-06-20 1996-06-20 Method and means for producing a fibrinogen binding protein and its use in biotechnology

Country Status (10)

Country Link
US (2) US6733758B1 (xx)
EP (1) EP0922056B1 (xx)
JP (1) JP4173549B2 (xx)
AT (1) ATE316979T1 (xx)
AU (1) AU3282597A (xx)
CA (1) CA2294433A1 (xx)
DE (1) DE69735207T2 (xx)
ES (1) ES2258280T3 (xx)
SE (1) SE9602496D0 (xx)
WO (1) WO1997048727A1 (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6685943B1 (en) 1997-01-21 2004-02-03 The Texas A&M University System Fibronectin binding protein compositions and methods of use
US6380370B1 (en) * 1997-08-14 2002-04-30 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
EP2319931A1 (en) * 1997-11-26 2011-05-11 Inhibitex, Inc. Extracellular matrix-binding proteins from staphylococcus aureus
US6692739B1 (en) * 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
JP2002523474A (ja) * 1998-08-31 2002-07-30 インヒビテツクス，インコーポレイテツド ドナーの選択およびドナーの刺激によるブドウ球菌の免疫療法
BR9913340A (pt) * 1998-08-31 2001-11-06 Inhibitex Inc Composição, vacina, e, processos de gerar uma resposta imune, e de inibir a colonização microbiana em um animal
AU772547B2 (en) * 1998-08-31 2004-04-29 Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin, The Polypeptides and polynucleotides from coagulase-negative staphylococci
US6703025B1 (en) 1998-08-31 2004-03-09 Inhibitex, Inc. Multicomponent vaccines
US20040038327A1 (en) * 1999-08-31 2004-02-26 Foster Timothy J. Antibodies to polypeptides from coagulase-negative staphylococci
EP2339344A1 (en) 2001-06-15 2011-06-29 Inhibitex, Inc. Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
WO2003076470A1 (en) * 2002-03-05 2003-09-18 Inhibitex, Inc. Monoclonal and polyclonal antibodies recognizing coagulase-negative staphylococcal proteins
BRPI0408167B1 (pt) 2003-03-07 2014-10-21 Wyeth Corp Conjugados de polissacarídeo-proteína veículo adesina da superfície estafilocócica para imunização contra infecções nosocomiais
US20080095777A1 (en) 2004-09-22 2008-04-24 Glaxosmithkline Biologicals S.A. Immunogenic Composition for Use in Vaccination Against Staphylococcei
JP2009531387A (ja) 2006-03-30 2009-09-03 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 免疫原性組成物
WO2007127339A2 (en) * 2006-04-26 2007-11-08 Tyco Healthcare Group Lp Multi-stage microporation device
MX2012000044A (es) 2009-06-22 2012-01-30 Wyeth Llc Composiciones inmunogenicas de antigenos de staphylococcus aureus.
EP2454284B1 (en) 2009-07-15 2018-04-11 AIMM Therapeutics B.V. Gram-positive bacteria specific binding compounds
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3583987D1 (de) 1984-11-06 1991-10-10 Thomae Gmbh Dr K Antibiotisches polypeptid, verfahren zu seiner herstellung und seine verwendung.
ES2059645T3 (es) * 1988-07-15 1994-11-16 Thomae Gmbh Dr K Procedimiento para la obtencion, el aislamiento y la purificacion de epidermina.
US5055455A (en) * 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
US5571511A (en) * 1990-10-22 1996-11-05 The U.S. Government Broadly reactive opsonic antibodies that react with common staphylococcal antigens
AU4837193A (en) 1992-09-21 1994-04-12 Alfa-Laval Agri International Aktiebolag Fibrinogen binding protein
IL109410A0 (en) * 1993-04-30 1994-07-31 Ell Lilly & Company Fema gene of staphylococcus epidermidis, fema protein, and vectors and microorganisms comprising the fema gene
US6107068A (en) * 1995-12-22 2000-08-22 The University Of British Columbia Coenzyme A disulfide reductase, and inhibitors thereof useful as antimicrobial agents

Also Published As

Publication number Publication date
CA2294433A1 (en) 1997-12-24
JP2001503609A (ja) 2001-03-21
US20040209326A1 (en) 2004-10-21
EP0922056A1 (en) 1999-06-16
JP4173549B2 (ja) 2008-10-29
DE69735207T2 (de) 2006-11-02
DE69735207D1 (de) 2006-04-13
US6733758B1 (en) 2004-05-11
WO1997048727A1 (en) 1997-12-24
AU3282597A (en) 1998-01-07
ES2258280T3 (es) 2006-08-16
EP0922056B1 (en) 2006-02-01
ATE316979T1 (de) 2006-02-15
US7160990B2 (en) 2007-01-09

Similar Documents

Publication Publication Date Title
SE9602496D0 (sv) Method and means for producing a fibrinogen binding protein and its use in biotechnology
ATE549347T1 (de) Gene von säugetiere, und damit verbundene reagentien, methoden
NZ502391A (en) Mammalian cytokine: interleukin-B30 and related reagents
DE69131580D1 (de) GDF-1 und UOG1 Proteine
DE262192T1 (de) Verfahren und mittel zur herstellung eines proteins mit dergleichen igg-spezifizitaet wie protein g.
JPS55104887A (en) Rearranged dna molecule and method
ATE337399T1 (de) Zusammensetzungen zur immuntherapie und diagnose von tuberculosis
NO179412C (no) Hybrid DNA-molekyl som koder for fibronektinbindende protein, mikroorganismer inneholdende slike DNA-molekyler samt fremgangsmåte ved fremstilling av slikt protein
ATE380867T1 (de) Lactoferrinrezeptorgen von moraxella
ATE229977T1 (de) Peptide mit antiproliferativen eigenschaften
ATE419358T1 (de) Gebrauchsverfaheren eines neuen lysyloxidase- verwandten proteins
NO177570C (no) Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper
WO1994026891A3 (en) Purified mammalian flt3 ligands and agonists and antagonists thereof
NO922421L (no) Collagenbindende protein, samt fremstilling derav
EP0990703A4 (en) NEW POLYPEPTIDE, FOR CODING DNA AND THEIR USE
DE69728897D1 (de) Saeugetierchemokine
DE60237613D1 (de) Neue pgc-1-isoformen und deren verwendungen
SE9704141D0 (sv) New protein and nucleotide sequence, encoding said protein
ATE122055T1 (de) Dna- und rna-moleküle des westlichen subtyps des fsme-virus, polypeptide, die von diesen molekülen codiert werden, und deren verwendung.
CY1110308T1 (el) Μοριο νουκλεϊνικου οξεος, το οποιο περιλαμβανει μια κωδικευσουσα για αιμοκυανινη ακολουθια νουκλεϊνικου οξεος και τουλαχιστον μια ακολουθια ιντρονιου
EP0887410A3 (en) DNA encoding a plasminogen activating protein
WO1998023752A3 (de) Papillomviren, mittel zu deren nachweis sowie zur therapie von durch sie verursachten erkrankungen
ATE351909T1 (de) Neue peptidfragmente zur reinigung von proteinen
SE0003573D0 (sv) Method and means for producing novel von Willebrand factor binding proteins and their use in biotechnology
WO2000055192A3 (de) Hämocyanin und dafür kodierende nukleinsäuresequenz